Replay available

Monte Rosa Therapeutics, Inc. (GLUE) Q4 2024 Earnings Call

Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) Q4 2024 earnings conference call, held 2025-03-20. Replay captured from the company's public earnings webcast.

Thu, March 20, 2025 at 8:00 AMendedReplay
Monte Rosa Therapeutics, Inc. (GLUE) Q4 2024 Earnings Call

Hosted by

Featured presenters

Not Provided

Safe Harbor/Legal Disclosure Presenter

Andrew Funderburk

Senior Vice President, Investor Relations & Strategic Finance

Marcus Wormuth

Chief Executive Officer

Philip Iancu

Chief Medical Officer

Sharon Townsend

Chief Scientific Officer

Kelly Shee

Analyst, Jefferies

Edward Tenthalt

Analyst, Piper Sandler

Mark Fromm

Analyst, TVCO

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Monte Rosa Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.017 Greetings and welcome to Monte Rosa Therapeutics conference call to discuss the company's 00:00:05.017 -- 00:00:10.123 pipeline updates and clinical results. At this time, all participants 00:00:10.123 -- 00:00:15.350 are in a listen-only mode. A question and answer session will follow the formal 00:00:15.350 -- 00:00:20.576 presentation. As a reminder, this conference call is being recorded. 00:00:20.576 -- 00:00:25.903 It is now my pleasure to introduce Andrew Funderburk, Senior 00:00:25.903 -- 00:00:30.878 Vice President, Investor Relations, and Strategic Finance at Monterosa. 00:00:30.878 -- 00:00:34.360 Thank you, Andrew. You may begin. 00:00:36.484 -- 00:00:37.145 Thank you. 00:00:37.145 -- 00:00:40.529 Good morning, everyone, and thank you for joining our conference call to discuss the 00:00:40.529 -- 00:00:43.933 clinical and preclinical updates across our pipeline. 00:00:43.933 -- 00:00:48.378 With us on today's call are Marcus Wormuth, Chief Executive Officer, Philip Iancu, Chief 00:00:48.378 -- 00:00:53.704 Medical Officer, Sharon Townsend, Chief Scientific Officer, and Phil Nixon, Chief Business 00:00:53.704 -- 00:00:56.124 and Legal Officer. 00:00:57.389 -- 00:01:01.593 Before we begin, I would like to remind everyone that any statements we make or information 00:01:01.593 -- 00:01:05.877 presented on this call that are not historical facts are forward-looking statements that 00:01:05.877 -- 00:01:09.840 are based on our current beliefs, plans, and expectations and are made pursuant to the 00:01:09.840 -- 00:01:14.965 safe harbor provisions of the Private Securities Litigation Reform Act of 1995. 00:01:14.965 -- 00:01:18.948 Please refer to our annual report and other filings we make with the SEC for our risk 00:01:18....